<DOC>
	<DOC>NCT02125279</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and efficacy of up to 26 weeks of treatment with calcitriol 3 mcg/g ointment when used twice daily, without occlusion, to treat pediatric subjects (2 to 16 years and 11 months of age) with mild to moderate plaque psoriasis.</brief_summary>
	<brief_title>Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Male or female 2 to 16 years and 11 months of age Clinical diagnosis of stable mild to moderate plaque psoriasis Other forms of psoriasis Hypercalcemia Past history of kidney stones Vitamin D deficiency Other concomitant dermatological disease</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>